Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3390 results

Sort By:

Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study

Study ID: NCT06662591
Start Date: 2025-12-27
End Date: 2028-05-27
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment
Sponsor

Research and Treatment Society of Genetic Disorders

Source: clinicaltrials.gov

Share:
Add to list

Pain Disengagement Training (open Pilot)

Study ID: NCT06870162
Start Date: 2025-06
End Date: 2026-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Pain Disengagement Training

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Study ID: NCT06719362
Start Date: 2025-10
End Date: 2030-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

110

Intervention / Treatment

M3T01

Pembrolizumab

Chemoradiation

FOLFOX regimen

Sponsor

Providence Health & Services

Source: clinicaltrials.gov

Share:
Add to list

OH2 Administered by Intratumoral Injection

Study ID: NCT05954091
Start Date: 2025-09-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

29

Intervention / Treatment

OH2 Injection

Sponsor

Binhui Biopharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Applicability of 3T Shoulder MRI in Detection of Labral Pathology

Study ID: NCT06043791
Start Date: 2025-09
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

78

Intervention / Treatment

1.5 Tesla magnet MR arthrography

3 Tesla magnet non-contrast MRI

Sponsor

Henry Ford Health System

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis

Study ID: NCT05060380
Start Date: 2025-06-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

44

Intervention / Treatment

Exercise training

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Study ID: NCT06660862
Start Date: 2025-11
End Date: 2029-11
Study Type

Interventional

Study Phase

Phase4

No. of Participants

80

Intervention / Treatment

Darolutami

Physician choice Androgen Deprivation (Hormone) Therapy

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Reporting Back Pesticide Results to Family Child Care Home Directors

Study ID: NCT06910462
Start Date: 2025-08-01
End Date: 2028-04-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Integrated pest management (IPM) practices

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Study ID: NCT06945380
Start Date: 2025-05-15
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Best Practice, Comparator Program

Best Practice, Usual Care

Internet-Based Intervention

Massage Therapy

Survey Administration

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

Study ID: NCT05936580
Start Date: 2025-09
End Date: 2027-02
Study Type

Interventional

Study Phase

Phase4

No. of Participants

28

Intervention / Treatment

Nuq

Sponsor

Octapharma

Source: clinicaltrials.gov

Share:
Add to list